NIFTY 24334.20 BANK 55087.15

Glenmark Pharmaceuticals Ltd.
Share Price Target & Analysis

NSE:GLENMARK

1386.56

VWAP

1384.4

Open

1384.4

Close

1406.6

High

1372

Low

1830.95

52 Week High

1381.20 ⇩
-3.20 (-0.23%)

GLENMARK

(PHARMA)
46.8% Momentum

Turnaround Potential

985.2

52 Week Low

215.32

EPS

46.53

PE

1.63

PB

Deluxe
Quality

Steel
Valuation

#Analysis

NSE: GLENMARK Share Price Financial Analysis & Valuation

Glenmark Pharmaceuticals Ltd. (GLENMARK) is broadly categorized in PHARMA segment industry which deals in Pharmaceuticals vertical. It is one of Mid Cap company with Market Capitalization of Rs 13448.1 (in Cr). Total number of free float shares are 0 (in Lacs). Glenmark Pharmaceuticals Ltd. is listed on NSE with Exchange ID - INE935A01035 and trading code is NSE:GLENMARK with short name Glenmark.

Glenmark Pharmaceuticals Ltd. is also traded in Future & Options (Derivative segment of NSE).

In the past 1 year, Glenmark Pharmaceuticals Ltd. has declared an equity dividend of Rs 2.5 per share. At the current share price of GLENMARK at Rs 1381.20, this results in a dividend yield of 0.18 %.

As per the Fundamental Analysis of NSE:GLENMARK, which uses revenues, earnings, future growth, financial ratios, return on equity, profit margins, and other data to determine GLENMARK underlying value and future prospects. All of this data is available in GLENMARK financial statements.

Quality of the Stock: As per the fundamental analysis of NSE:GLENMARK, it is clearly understood that GLENMARK is Deluxe performer in terms of earnings and profit margins with an EPS of 215.32. NSE:GLENMARK book value per share as of today is 848.54. The current price to book ratio for GLENMARK as of May 01, 2025 is 1.63.

Valuation of the Stock: The current valuation of GLENMARK stock is like Steel which means currently the stock is Moderately Priced. Now, it's totally depends upon the risk appetite of an investor and risk-reward ratio of GLENMARK whether to BUY this stock at current valuation. The delivery percentage of GLENMARK is 45.95% is very crucial parameter which shows that 45.95% investors are anticipating that the price of GLENMARK share should go up with VWAP at 1386.56.

Now, the main question is whether to BUY or SELL, NSE:GLENMARK at current valuation.
As per latest Analysis No. #1106:-

⇑ STRONG BUY GLENMARK if All Greens

⇗ BUY GLENMARK (at Lower Levels) if any 2 Greens

⇒ NEUTRAL or HOLD GLENMARK (With Stop Loss) if only 1 Green

⇘ SELL GLENMARK if NO Green Indicator

NSE: GLENMARK Share Price Today (May 01, 2025)

(Glenmark Pharmaceuticals Ltd. Daily Analysis on the basis of GLENMARK Intraday Graph & Trend)

Glenmark Pharmaceuticals Ltd. share price moved Down by -0.23% from its previous close of Rs 1384.4. GLENMARK stock last traded price is 1381.20. GLENMARK share price trend is Down with a total of 694501 stocks traded till now. It has touched an intraday high of Rs 1406.6 and an intraday low of Rs 1372. The GLENMARK trading at 1381.20, Down by Rs. -3.20, or -0.23 percent which suggests that most of the Traders are anticipating that the price of GLENMARK share should go Down.

NSE: GLENMARK Share Price Tomorrow Prediction

(Glenmark Pharmaceuticals Ltd. Share Price Prediction for Tomorrow & future forecast is based on Current Trend of GLENMARK)

Glenmark Pharmaceuticals Ltd. share price moved Down by -0.23%. GLENMARK share price short term trend is Down. It suggests that GLENMARK Share Price for Tomorrow remains the same with VWAP at 1386.56 will be treated as stop loss for intraday traders. Glenmark Pharmaceuticals Ltd. Long term investors can follow the GLENMARK long term trend as mentiond in future forecast table.

NSE Code

NSE: GLENMARK

GLENMARK Share Price Today

 1381.20

GLENMARK Share Price Target Prediction for 2025 ^

 1032.9 - 1547.6

GLENMARK Share Price Target Prediction for 2026*^

 1547.6 - 2066.6

GLENMARK Share Price Target Prediction for 2027*^

 2066.6 - 2213.7

GLENMARK Share Price Target Prediction for 2028*^

 2324

GLENMARK Share Price Target Prediction for 2029*^

 2394

GLENMARK Share Price Target Prediction for 2030*^

 2612
GLENMARK Current Book Value 2024
844.3

*Glenmark Pharmaceuticals Ltd. Short Term & Long Term share price target is based on current financial year earings of the company.
^GLENMARK share price target prediction for 2025 2026 2027 to 2030 is based on current market scenario, future forecast & growth assumptions, they might change subject to market sentiments.

GLENMARK Technical Analysis

Candlestick Pattern: @1325.15

GLENMARK Moving Averages

BUY (0) NEUTRAL (0) SELL (14)
MA Simple Action S1 Expo Action E2
MA_5 1344.73 SELL 1340.15 SELL
MA_12 1403.23 SELL 1381.76 SELL
MA_20 1419.69 SELL 1406.12 SELL
MA_32 1447.46 SELL 1440.62 SELL
MA_50 1490.62 SELL 1468.24 SELL
MA_100 1534.8 SELL 1498.07 SELL
MA_200 1486.46 SELL 1425.86 SELL

GLENMARK Trend Oscillators

BUY (1) NEUTRAL (0) SELL (3)
Trend Oscillators Value Action
Bollinger Bands 1419.69 Downtrend
MACD -9.96 SELL
ADX 30.15 Strong Trend
DMI (+/-) 11.12 / 34.35 Downtrend

GLENMARK Momentum Oscillators

BUY (0) NEUTRAL (9) SELL (3)
Momentum Oscillators Value Action
RSI 36.93 Neutral
STOCHASTIC_K (Fast) 34.9 Neutral
STOCHASTIC_D (Slow) 36.56 Neutral
CCI -96.89 Neutral
PSAR 1469.01 SELL
TRUE RANGE 73.5 Neutral
ATR 58.02 Neutral
WILLIAMS R -83.58 Oversold
TRIX 0 Neutral
STOCHASTIC RSI K 54.25 Neutral
STOCHASTIC RSI D 39.5 Neutral
MOMENTUM -75.25 SELL

GLENMARK Last 1 Year Trend

Duration Value
1 Year 45.23%
3 Months -11.09%
1 Month -5.37%
1 Week -3.54%

GLENMARK Technical Analysis Summary

Updated on 2025-02-24
Action Overall (%)
BUY 3%
NEUTRAL / HOLD 30%
SELL 67%

Most popular Questions & Answers about GLENMARK


Glenmark Pharmaceuticals Ltd. stock last traded price is 1381.20. GLENMARK share price moved Down by -0.23% from its previous close of Rs 1384.4.

Glenmark Pharmaceuticals Ltd. share price trend is Down with a total of 694501 stocks traded till now. It has touched an intraday high of Rs 1947.39975 and an intraday low of Rs 1372. The GLENMARK trading at 1381.20, Down by Rs. -3.20, or -0.23 percent which suggests that most of the Traders are anticipating that the price of GLENMARK share should go Down and the Stop Loss will be around 1386.56.

The market cap of Glenmark Pharmaceuticals Ltd. is ₹13448.1 (in Cr) as of Apr 30, 2025.

The current price to earning ratio for Glenmark Pharmaceuticals Ltd. as of Apr 30, 2025 is 46.53.

The current price to book ratio for Glenmark Pharmaceuticals Ltd. as of Apr 30, 2025 is 1.63.

The highest price of Glenmark Pharmaceuticals Ltd. stock is ₹1830.95 in the last 52-week.

The lowest price of Glenmark Pharmaceuticals Ltd. stock is ₹985.2 in the last 52-week.

Glenmark Pharmaceuticals Ltd. share trading at ₹1381.20, Down by Rs. -3.20, or -0.23 percent which suggests that most of the traders are anticipating that the price of GLENMARK share should go Down.

In 2023, Stock price target for Glenmark Pharmaceuticals Ltd. (GLENMARK) are ₹1032.9 on downside and ₹1547.6 on upside. Glenmark Pharmaceuticals Ltd. share price target is based on current financial year earings of the company.

In 2024, Stock price target for Glenmark Pharmaceuticals Ltd. (GLENMARK) are ₹1547.6 on downside and ₹2066.6 on upside. Glenmark Pharmaceuticals Ltd. share price target is based on forecasted future earnings of the company.

In 2025, Stock price target for Glenmark Pharmaceuticals Ltd. (GLENMARK) are ₹2066.6 on downside and ₹2213.7 on upside. Glenmark Pharmaceuticals Ltd. share price target is based on Discounted Cash Flow (DCF) method uses the projected future cash flows of the business.

In next five years, Stock price target for Glenmark Pharmaceuticals Ltd. (GLENMARK) will be around ₹2394 Glenmark Pharmaceuticals Ltd. share price target is based on market scenario & growth assumptions, they might change subject to market sentiments and forecasted future earnings of GLENMARK.

The price of Glenmark Pharmaceuticals Ltd. (GLENMARK) shares moved by -0.23%. The short-term trend for GLENMARK share price is Down. It implies that the share price of GLENMARK will stay the same tomorrow and that intraday traders should treat VWAP at 1386.56 as a stop loss. Investors with a long-term outlook can track GLENMARK long-term trajectory, which is indicated in the future forecast table.

Estimated DCF Value of GLENMARK stock is 2581.7. Compared to the current market price of 1381.20 INR, the GLENMARK stock is Undervalued by 46.5%.

As per the fundamental analysis of Glenmark Pharmaceuticals Ltd. (GLENMARK), it is of Deluxe quality in terms of earnings and profit margins with an EPS of 215.32. Glenmark Pharmaceuticals Ltd. book value per share as of today is 848.54. The current price to book ratio for GLENMARK as of May 01, 2025 is 1.63.


NSE:GLENMARK News & Other Useful Information about GLENMARK Share Price


Peer Comparison of NSE: GLENMARK

The Peers list includes companies operating in the same industry and having comparable market cap.

Sector: Pharmaceuticals

Company Price EPS BV
SUNPHARMA 1832.30 13.13 98.33
DIVISLAB 6087.00 78.09 513.62
MEDICAMEQ 426.85 7.48 163.16
CIPLA 1550.10 58.33 360.73
DRREDDY 1183.90 62.12 322.46
PGHH 15925.70 189.8 324.25
TORNTPHARM 3322.00 53.89 222.38
BIOCON 321.80 5.01 90.7
LUPIN 2095.60 67.15 481.38
ALKEM 5116.00 194.78 984.46
Updated at: 30 Apr 2025 15:58

Feel free to contact us, in case of any queries.

SITEMAP 3165
Disclaimer: Published information or data available on the Website may not be current or up to date and also any information or data available on this website may contain inaccuracies and/or typographical errors. Kindly refer any reliable source for its accuracy. If you select any of these stocks for your trades, you do so at your own risk.

Stocks to Watch Today

ADANIENT 2301.30 -29.30 (-1.26%) | ADANIGREEN 900.70 -21.70 (-2.35%) | ADANIPORTS 1216.50 0.10 (0.01%) | ADANITRANS 1010.05 -18.55 (-1.8%) | AMBUJACEM 539.70 5.75 (1.08%) | APOLLOHOSP 6977.00 -15.50 (-0.22%) | ASIANPAINT 2425.70 -25.40 (-1.04%) | ATGL 600.20 -9.55 (-1.57%) | AUROPHARMA 1229.10 19.50 (1.61%) | AXISBANK 1185.00 -2.30 (-0.19%) | BAJAJ-AUTO 8030.00 -48.50 (-0.6%) | BAJAJFINSV 1951.60 -115.30 (-5.58%) | BAJFINANCE 8634.50 -458.50 (-5.04%) | BALKRISIND 2675.10 77.40 (2.98%) | BANDHANBNK 165.62 -2.28 (-1.36%) | BANKBARODA 249.93 -3.29 (-1.3%) | BEL 314.10 -3.00 (-0.95%) | BERGEPAINT 544.20 -1.75 (-0.32%) | BHARTIARTL 1864.50 40.70 (2.23%) | BIOCON 321.80 2.95 (0.93%) | BOSCHLTD 29455.00 290.00 (0.99%) | BPCL 310.05 -1.65 (-0.53%) | BRITANNIA 5438.90 -29.40 (-0.54%) | CADILAHC 1100.00 -15.15 (-1.36%) | CIPLA 1550.10 8.60 (0.56%) | COALINDIA 385.30 -3.80 (-0.98%) | COLPAL 2587.40 -56.80 (-2.15%) | DABUR 487.75 4.10 (0.85%) | DIVISLAB 6087.00 -21.00 (-0.34%) | DLF 674.30 15.45 (2.34%) | DMART 4199.90 -110.10 (-2.55%) | DRREDDY 1183.90 7.90 (0.67%) | EICHERMOT 5567.00 -12.00 (-0.22%) | GAIL 189.09 -0.51 (-0.27%) | GLAND 1400.00 -12.90 (-0.91%) | GODREJCP 1260.50 -2.20 (-0.17%) | GRASIM 2737.50 -8.20 (-0.3%) | GUJGASLTD 453.50 -14.95 (-3.19%) | HAVELLS 1601.00 -21.80 (-1.34%) | HCLTECH 1567.50 -1.50 (-0.1%) | HDFC 2724.30 0.00 (0%) | HDFCAMC 4374.40 -41.60 (-0.94%) | HDFCBANK 1925.00 16.20 (0.85%) | HDFCLIFE 743.70 28.65 (4.01%) | HEROMOTOCO 3827.40 -25.30 (-0.66%) | HINDALCO 624.65 2.10 (0.34%) | HINDUNILVR 2342.10 20.40 (0.88%) | HINDZINC 439.20 -6.25 (-1.4%) | ICICIBANK 1427.00 -2.80 (-0.2%) | ICICIGI 1876.50 20.40 (1.1%) | ICICIPRULI 614.35 9.10 (1.5%) | INDIGO 5249.50 -14.50 (-0.28%) | INDUSINDBK 838.40 1.45 (0.17%) | INDUSTOWER 408.20 5.60 (1.39%) | INFY 1500.10 2.60 (0.17%) | IOB 37.53 -0.81 (-2.11%) | IOC 137.86 2.08 (1.53%) | ITC 425.80 -0.20 (-0.05%) | JSWSTEEL 1029.80 -5.80 (-0.56%) | KOTAKBANK 2208.10 3.10 (0.14%) | LT 3341.00 18.70 (0.56%) | LTI 6149.30 78.10 (1.29%) | LUPIN 2095.60 28.50 (1.38%) | M&M 2928.80 19.20 (0.66%) | MARICO 710.45 -0.90 (-0.13%) | MARUTI 12257.00 416.00 (3.51%) | MCDOWELL-N 1485.00 -14.35 (-0.96%) | MOTHERSUMI 187.83 -5.36 (-2.77%) | MUTHOOTFIN 2169.90 17.60 (0.82%) | NAUKRI 7069.50 10.50 (0.15%) | NESTLEIND 2388.20 0.70 (0.03%) | NMDC 64.79 -0.78 (-1.19%) | NTPC 354.55 -2.40 (-0.67%) | ONGC 244.45 -1.23 (-0.5%) | PEL 967.95 -20.70 (-2.09%) | PIDILITIND 3033.90 28.90 (0.96%) | PIIND 3640.20 -7.50 (-0.21%) | PNB 100.21 -2.42 (-2.36%) | POWERGRID 307.45 4.50 (1.49%) | RELIANCE 1405.00 5.30 (0.38%) | SAIL 113.71 -1.57 (-1.36%) | SBICARD 873.55 -4.85 (-0.55%) | SBILIFE 1765.80 35.70 (2.06%) | SBIN 788.65 -23.90 (-2.94%) | SHREECEM 29710.00 -315.00 (-1.05%) | SIEMENS 2901.50 -28.50 (-0.97%) | SRF 3008.90 -11.60 (-0.38%) | SUNPHARMA 1832.30 26.80 (1.48%) | TATACONSUM 1165.80 -3.10 (-0.27%) | TATAMOTORS 644.25 -21.35 (-3.21%) | TATAMTRDVR 768.65 33.35 (4.54%) | TATASTEEL 140.08 -1.42 (-1%) | TCS 3453.70 -18.80 (-0.54%) | TECHM 1503.00 7.70 (0.51%) | TITAN 3379.70 1.10 (0.03%) | TORNTPHARM 3322.00 -0.70 (-0.02%) | ULTRACEMCO 11641.00 -228.00 (-1.92%) | UPL 669.90 0.30 (0.04%) | VEDL 419.20 2.90 (0.7%) | WIPRO 241.50 0.10 (0.04%) |